Salvatore Chibbaro, Fabrice Vallee, Marco Marsella, Leonardo Tigan, Thomas Lilin, Benoit Lecuelle, Bernard George, Pierre Kehrli, Eric Vicaut, Paolo Diemidio
Department of Neurosurgery, Strasbourg University Hospital, Strasbourg, Paris, France ; Department of Neurosurgery, Laribosiere University Hospital, Paris, France.
ICU, Laribosiere University Hospital, Paris, France.
J Neurosci Rural Pract. 2013 Oct;4(4):421-6. doi: 10.4103/0976-3147.120244.
Decompressive craniectomy (DC) is a procedure performed increasingly often in current neurosurgical practice. Significant perioperative morbidity may be associated to this procedure because of the large skull defect; also, later closure of the skull defect (cranioplasty) may be associated to post-operative morbidity as much as any other reconstructive operation. The authors present a newly conceived/developed device: The "Skull Flap" (SF). This system, placed at the time of the craniectomy, offers the possibility to provide cranial reconstruction sparing patients a second operation. In other words, DC and cranioplasty essentially take place at the same time and in addition, patients retain their own bone flap. The current study conducted on animal models, represents the logical continuation of a prior recent study, realized on cadaver specimens, to assess the efficacy and safety of this recently developed device.
This is an experimental pilot study on dogs to assess both safety and efficacy of the SF device. Two groups of experimental raised intracranial pressure animal models underwent DC; in the first group of dogs, the bone flap was left in raised position above the skull defect using the SF device; on the second group the flap was discarded. All dogs underwent transcranial Doppler (TCD) to assess brain perfusion. Head computed tomography (CT) scan to determine flap position was also obtained in the group in which the SF device was placed.
SF has proved to be a strong fixation device that allows satisfactory brain decompression by keeping the bone flap elevated from the swollen brain; later on, the SF allows cranial reconstruction in a simple way without requiring a second staged operation. In addition, it is relevant to note that brain perfusion was measured and found to be better in the group receiving the SF (while the flap being in a raised as well as in its natural position) comparing to the other group.
The SF device has proved to be very easy to place, well-adaptable to a different type of flaps and ultimately very effective in maintaining satisfactory brain decompression and later on, making easy bone flap repositioning after brain swelling has subsided.
减压性颅骨切除术(DC)是当前神经外科手术中越来越常施行的一种手术。由于颅骨缺损较大,该手术可能伴有显著的围手术期发病率;此外,颅骨缺损后期的闭合(颅骨成形术)与其他任何重建手术一样,可能伴有术后发病率。作者介绍了一种新构思/研发的装置:“颅骨瓣”(SF)。该系统在颅骨切除时放置,为颅骨重建提供了可能,使患者无需进行二次手术。换句话说,DC和颅骨成形术基本同时进行,此外,患者保留了自己的骨瓣。目前在动物模型上进行的这项研究,是先前在尸体标本上进行的一项近期研究的合理延续,旨在评估这种新研发装置的有效性和安全性。
这是一项在犬类动物上进行的实验性初步研究,以评估SF装置的安全性和有效性。两组实验性颅内压升高动物模型接受了DC;在第一组犬中,使用SF装置将骨瓣留在颅骨缺损上方的抬高位置;在第二组中,骨瓣被丢弃。所有犬均接受经颅多普勒(TCD)检查以评估脑灌注。在放置了SF装置的组中,还进行了头部计算机断层扫描(CT)以确定骨瓣位置。
SF已被证明是一种强大的固定装置,通过使骨瓣与肿胀的大脑保持抬高,可实现令人满意的脑减压;随后,SF能够以简单的方式进行颅骨重建,无需二期手术。此外,值得注意的是,测量发现接受SF的组(骨瓣处于抬高以及自然位置时)的脑灌注比另一组更好。
SF装置已被证明非常易于放置,能很好地适应不同类型的骨瓣,最终在维持令人满意的脑减压方面非常有效,并且在脑肿胀消退后能轻松进行骨瓣重新定位。